Vir Biotechnology
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $1,214 | $1,794 | $11,278 | $2,380 |
Gross Profit | 1,203 | 1,794 | 10,594 | 2,330 |
EBITDA | -118,417 | -136,690 | -114,058 | -215,696 |
EBIT | -139,557 | -116,944 | -218,592 | |
Net Income | -110,958 | -120,965 | -104,589 | -213,717 |
Net Change In Cash | 1,214 | 1,794 | 11,278 | 2,380 |
Free Cash Flow | -122,757 | -79,745 | -90,042 | -173,836 |
Cash | 299,322 | 273,571 | 222,947 | 168,350 |
Basic Shares | 138,447 | 137,469 | 136,809 | 136,654 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $74,205 | $86,180 | $1,580,472 | $1,087,068 |
Gross Profit | 73,360 | 83,415 | 1,434,153 | 1,021,203 |
EBITDA | -537,611 | -664,854 | 833,068 | 420,751 |
EBIT | -552,170 | -684,305 | 817,576 | 408,768 |
Net Income | -521,960 | -615,061 | 515,837 | 528,584 |
Net Change In Cash | 74,205 | 86,180 | 1,580,472 | 1,087,068 |
Cost of Revenue | -88,072 | |||
Free Cash Flow | -453,653 | -800,358 | 1,595,225 | -69,406 |
Cash | 222,947 | 241,576 | 848,631 | 347,815 |
Basic Shares | 136,247 | 134,130 | 134,810 | 133,437 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.80 |
2025-03-31 | -$0.88 |
2024-12-31 | -$0.76 |
